Various alphabetized medical records
Industries

Life Sciences Litigation

CRA’s life sciences litigation support services are grounded in a comprehensive understanding of pharmaceutical, biotechnology, medical device, and diagnostic markets. For more than 30 years, our experts have consulted with major life science companies, law firms, and regulatory agencies around the globe. We provide clients with the industry and analytical expertise needed to solve our clients’ most complex issues.

CRA has a reputation for delivering rigorous analysis and expert testimony. Economic expertise is complemented by experience assisting life sciences companies with business and policy issues. This combination allows CRA to provide effective expert testimony and support.

Our Focus Areas

Engagements

  • 01
    Economic analysis in a product hopping litigation
    This case involved a blood thinner drug whose initial patent had expired. The brand company improved the product and obtained additional patents on those...
    View engagement
  • 02
    Economic analysis of generic test specification standards
    This matter involved scientific tests for generic drug closeness to the brand, as required by the FDA. The plaintiff alleged deceptive conduct within the...
    View engagement
  • 03
    Breach of a global co-marketing deal: Swiss arbitration
    Situation: Our client, a major pharmaceutical manufacturer, had to prove damages from the wrongful termination of its global co-marketing/co-promotion rights...
    View engagement

Subscribe to receive our latest Insights.

Subscribe